Author

Judit Morelló

Observed names: J Morello, J. Morello, Judit Morello, Judith Morello, Morello J, Morello, J.

Institution: Universidade Nova de Lisboa

Observed institutions: Roche (Switzerland), Leiden University, University of Lisbon, Leiden University Medical Center, Cancer Research UK, Instituto de Salud Carlos III, Madrid Health Service, Carlos III Hospital, Instituto Superior Técnico, Centro de Química Estrutural, Veristat, LLC (United States), Universidade Nova de Lisboa

ORCID: 0000-0002-1148-9329

Observed ORCID: 0000-0002-1148-9329

OpenAlex ID: A5016018012

Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

2009 · Sonia Rodríguez‐Nóvoa, Pablo Labarga, et al. · Clinical Infectious Diseases · 241

PDF

Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C

2008 · J. Morello, S. Rodriguez-Novoa, et al. · Journal of Antimicrobial Chemotherapy · 85

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

2007 · V. Soriano, P. Garcia-Gasco, et al. · Journal of Antimicrobial Chemotherapy · 79

PDF

Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence

2021 · N. R. Coelho, A. B. Pimpão, et al. · Journal of Molecular Medicine · 66

PDF

Metabolic Dysfunction and Asthma: Current Perspectives

2020 · Helena Pite, Laura Aguiar, et al. · Journal of Asthma and Allergy · 54

PDF

Raltegravir and Etravirine Are Active against HIV Type 1 Group O

2009 · Verónica Briz, Carolina Garrido, et al. · AIDS Research and Human Retroviruses · 45

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

2008 · I. Jimenez-Nacher, B. Garcia, et al. · Journal of Antimicrobial Chemotherapy · 44

PDF

Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701

2010 · S. Rodriguez-Novoa, L. Cuenca, et al. · Journal of Antimicrobial Chemotherapy · 41

Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

2008 · Sonia Rodríguez-Nóvoa, Judit Morello, et al. · AIDS · 41

Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine

2022 · Maria João Correia, António B. Pimpão, et al. · Molecules · 40

PDF

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

2011 · Inmaculada Jiménez-Nácher, Elena Alvarez, et al. · Expert Opinion on Drug Metabolism & Toxicology · 39

Noncirrhotic portal hypertension in HIV infection

2010 · Eugenia Vispo, Judit Morello, et al. · Current Opinion in Infectious Diseases · 38

Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring

2008 · Sonia Rodríguez-Nóvoa, Judit Morello, et al. · AIDS Research and Human Retroviruses · 38

Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon–Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection

2010 · Judit Morello, Lorena Cuenca, et al. · The Journal of Infectious Diseases · 37

Usefulness of zebrafish larvae to evaluate drug-induced functional and morphological renal tubular alterations

2017 · Rita Gorgulho, Raquel Jacinto, et al. · Archives of Toxicology · 36

PDF

Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes

2011 · Susanna Naggie, Norma I. Rallon, et al. · The Journal of Infectious Diseases · 33

RETRACTED ARTICLE: Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial

2010 · Eugenia Vispo, Pablo Barreiro, et al. · HIV Clinical Trials · 32

PDF

Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge

2017 · Natalia Marto, Judit Morello, et al. · Drug Metabolism Reviews · 25

Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse

2010 · Pablo Labarga, Eugenia Vispo, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 24

Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity

2023 · Pedro Baltazar, Antonio Ferreira de Melo Junior, et al. · Genes · 22

PDF

AHR canonical pathway: in vivo findings to support novel antihypertensive strategies

2021 · Nuno R. Coelho, Clara Matos, et al. · Pharmacological Research · 22

Mass Spectrometry-Based Methodologies for Targeted and Untargeted Identification of Protein Covalent Adducts (Adductomics): Current Status and Challenges

2019 · João Nunes, Catarina Charneira, et al. · Microarrays · 22

PDF

Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations

2011 · Carolina Garrido, Carmen de Mendoza, et al. · AIDS Research and Human Retroviruses · 22

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

2010 · Judit Morello, Vincent Soriano, et al. · Antimicrobial Agents and Chemotherapy · 22

Measurement of Ribavirin Plasma Concentrations by High-performance Liquid Chromatography Using a Novel Solid-phase Extraction Method in Patients Treated for Chronic Hepatitis C

2007 · Judit Morello, Sonia Rodríguez-Nóvoa, et al. · Therapeutic Drug Monitoring · 22

Works count: 71

Citation count: 1,462

H-index: 22

I10-index: 40